Search by Drug Name or NDC

NDC 72789-0173-01 Lithium Carbonate 300 mg/1 Details

Lithium Carbonate 300 mg/1

Lithium Carbonate is a ORAL CAPSULE, GELATIN COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by PD-Rx Pharmaceuticals, Inc.. The primary component is LITHIUM CARBONATE.

MedlinePlus Drug Summary

Lithium is used to treat and prevent episodes of mania (frenzied, abnormally excited mood) in people with bipolar disorder (manic-depressive disorder; a disease that causes episodes of depression, episodes of mania, and other abnormal moods). Lithium is in a class of medications called antimanic agents. It works by decreasing abnormal activity in the brain.

Related Packages: 72789-0173-01
Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Lithium

Product Information

NDC	72789-0173
Product ID	72789-173_f49a7dc7-77f6-3911-e053-2a95a90ad55c
Associated GPIs	59500010100105
GCN Sequence Number	004001
GCN Sequence Number Description	lithium carbonate CAPSULE 300 MG ORAL
HIC3	H2M
HIC3 Description	BIPOLAR DISORDER DRUGS
GCN	15710
HICL Sequence Number	001669
HICL Sequence Number Description	LITHIUM CARBONATE
Brand/Generic	Generic
Proprietary Name	Lithium Carbonate
Proprietary Name Suffix	n/a
Non-Proprietary Name	Lithium Carbonate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CAPSULE, GELATIN COATED
Route	ORAL
Active Ingredient Strength	300
Active Ingredient Units	mg/1
Substance Name	LITHIUM CARBONATE
Labeler Name	PD-Rx Pharmaceuticals, Inc.
Pharmaceutical Class	Mood Stabilizer [EPC]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA017812
Listing Certified Through	2024-12-31

Package

NDC 72789-0173-01 (72789017301)

Pricing Information	N/A
NDC Package Code	72789-173-01
Billing NDC	72789017301
Package	100 CAPSULE, GELATIN COATED in 1 BOTTLE, PLASTIC (72789-173-01)
Marketing Start Date	2021-03-09
NDC Exclude Flag	N